Endocyte, Inc. (ECYT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
3.12-0.01 (-0.32%)
At close: 4:00 PM EDT
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close3.13
Bid3.00 x 400
Ask0.00 x
Day's Range3.08 - 3.16
52wk Range2.65 - 5.63
1y Target EstN/A
Market Cap131.86M
P/E Ratio (ttm)-2.99
Avg Vol (3m)127,459
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • GlobeNewswire6 days ago

    Endocyte to Present at the Ladenburg Thalmann 2016 Healthcare Conference

    WEST LAFAYETTE, Ind., Sept. 20, 2016-- Endocyte, Inc., a leader in developing targeted small molecule drug conjugates and companion imaging agents for personalized therapy, today announced that the company’ ...

  • GlobeNewswire21 days ago

    INVESTIndiana announces executive presentation schedule

    Lineup highlights health sciences, banking, energy, high-tech and manufacturing Conference features inaugural Indiana Public Company of the Year Award Central Indiana Corporate Partnership CEO David Johnson's ...

  • Capital Cube25 days ago

    ETF’s with exposure to Endocyte, Inc. : September 2, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Endocyte, Inc. Here are 5 ETF’s with the largest exposure to ECYT-US. Comparing the performance and risk of Endocyte, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)